$RMD

22 stories mentioning RMDUpdated just now

Every FINWIRES story that references RMD, newest first.

Baird Adjusts Price Target on ResMed to $254 From $272, Maintains Neutral Rating

ResMed (RMD) has an average rating of overweight and mean price target of $304.80, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $228.68, Change: $-2.01, Percent Change: -0.87%

$RMD

Wire116d ago

Mizuho Adjusts Price Target on ResMed to $255 From $300, Maintains Outperform Rating

ResMed (RMD) has an average rating of overweight and mean price target of $305.30, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $228.56, Change: $-0.31, Percent Change: -0.14%

$RMD

Showing 21-22 of 22

Track with the FINWIRES app suite

FolioX

Track RMD in your portfolio

WheelAI

Analyze RMD options with the wheel strategy

StockInsider

See market sentiment on RMD